From Name:
From Email:
To Name:
To Email:

Optional Message:


Measurable residual disease status: a strong prognostic indicator in B-cell acute lymphoblastic leukemia

from Cancer Therapy Advisor

Measurable residual disease should be considered a treatment-informing prognostic marker among patients with B-cell acute lymphocytic leukemia (B-ALL), according to research published in Haematologica. Previous research has suggested that MRD is a good prognostic indicator of whether patients with B-ALL are likely to have disease recurrence after reaching complete disease remission, though evidence on this subject is conflicting. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063